Table 3 Univariable and multivariable analysis to identify predictors of overall survival of HCC patients after radical resection

Age (years)

0.993

0.974

1.012

0.449

Sex (male/female)

0.716

0.399

1.286

0.264

BCLC stage (0/A/B)

1.484

1.009

2.182

0.045

HBsAg (negative/positive)

1.546

0.775

3.084

0.216

HBV-DNA (< 5 × 10²IU/ml/≧5 × 10²IU/ml)

1.855

1.151

2.988

0.011

1.791

1.093

2.933

0.021

Anti-HCV (negative/positive)

0.455

0.063

3.284

0.435

Tumor diameter (cm)

1.116

1.066

1.169

< 0.001

1.073

1.018

1.131

0.009

Tumor number (1/≥2)

1.415

0.913

2.193

0.121

Tumor envelope (complete/incomplete)

2.281

1.459

3.569

< 0.001

2.169

1.368

3.440

0.001

Ascites (negative/positive)

1.862

1.055

3.286

0.032

1.659

0.922

2.985

0.091

AFP (<400 ng/ml/≥400 ng/ml)

1.237

0.824

1.857

0.305

WBC (*10⁹/L)

1.006

0.909

1.112

0.913

N% (%)

1.018

0.998

1.039

0.082

L% (%)

0.977

0.955

1.001

0.056

HB (g/L)

0.998

0.987

1.010

0.771

PLT (*10⁹/L)

1.000

0.997

1.003

0.996

FPG (mmol/L)

1.017

0.915

1.130

0.756

PT (s)

1.041

0.876

1.237

0.651

INR

1.658

0.310

8.872

0.554

TBiL (μmol/L)

0.989

0.959

1.021

0.505

Alb (g/L)

0.974

0.930

1.020

0.268

PA (mg/L)

0.996

0.994

0.999

0.018

0.998

0.995

1.001

0.268

ALT (U/L)

0.997

0.989

1.004

0.396

AST (U/L)

1.001

0.996

1.006

0.603

GGT (U/L)

1.002

1.001

1.003

0.001

1.002

1.000

1.003

0.024

ALP (U/L)

1.006

1.003

1.008

< 0.001

1.004

1.001

1.008

0.026

CK19 (negative/positive)

1.641

1.060

2.540

0.026

1.471

0.936

2.313

0.094

MVI (negative/positive)

2.132

1.409

3.225

< 0.001

1.808

1.171

2.787

0.007